Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AML3D LIMITED Capital/Financing Update 2023

Feb 6, 2023

64357_rns_2023-02-06_c0826e86-ce70-4d8d-9751-e5b0a7307dd8.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

ASX Release 7 February 2023

==> picture [52 x 47] intentionally omitted <==

AML3D RAISES $3M THROUGH A PLACEMENT TO SOPHISTICATED INVESTORS

HIGHLIGHTS

  • AML3D has raised $3m (before costs) through a Placement and will consider options for existing shareholder participation on the same terms

  • Funds will be utilised to expand AML3D’s US presence following its ARCEMY[® ]X-Edition 6700’ system sale to the US Department of Defence and invest in ARCEMY[®] platform software development

AML3D Limited (ASX:AL3) (" AML3D " or " the Company ") is pleased to announce that it has received firm commitments to raise $3m (before costs) via a Placement of shares to a range of Sophisticated Investors.

The successful Placement is following on from AML3D’s groundbreaking US Defence industry entry through a AUD$1.0 million ARCEMY® ‘X-Edition 6700’ system sale to BlueForge Alliance. The capital injection will ensure the Company is well funded as it continues to expand its presence within the US maritime and defence sectors, with more positive news in the pipeline.

Placement Details

The Placement shares will be issued at $0.072 per share, being a 23.8% discount to the volume-weighted-average-price (VWAP) of the Company’s shares on the ASX over the 15 days prior to the trading halt announcement. Up to 41,666,667 new ordinary shares will be issued, utilising the Company’s placement capacity under ASX Listing Rules 7.1 and 7.1A. The Placement shares will rank pari passu with AML3D’s existing ordinary share capital.

Taylor Collison Stockbrokers acted as Lead Manager to the Placement and Adelaide Equity Partners Limited was engaged to act as corporate advisor to the Placement.

Use of Funds

Establish a presence at key US bases

AML3D will establish a presence at key US additive manufacturing bases in Knoxville, TN and Danville, VA to service the US navy and other Tier 1 clients.

Knoxville is home to the largest science and energy national laboratory in the Department of Energy system and major partner to NAVSEA (US Navy), Boeing and other strategic targets.

Page Page | 1

AML3D Limited (ASX:AL3) ACN 602 857 983 | Australian Patent 2019251514

ASX Release 7 February 2023

==> picture [52 x 47] intentionally omitted <==

Danville houses the NAVSEA Additive Manufacturing Centre of Excellence, which includes 3 full bays dedicated to accelerating and scaling additive manufacturing and activating supply chains through a centralised Navy demand signal.

Form a US sales team

AML3D will establish a US sales team to identify distributors and value-added resellers to create a channel sales model for the ARCEMY[®] product line, positioning the Company to access the massive and high growth US additive manufacturing market.

Invest in ARCEMY[®] platform software development

AML3D will invest in expanding its software development team and capabilities to build out a feature rich platform and meet client requirement for an enhanced ARCEMY[® ] platform.

AML3D Chief Executive Officer, Ryan Millar, commented:

“Completion of a successful Placement will ensure AML3D can comfortably act on our US market growth ambitions and continue to support and expand on strategic partnerships such as our recent opportunity with the US Navy.

We intend to scale the Company within the massive and growing US additive manufacturing market utilising a fully functional US sales team and key bases in strategic locations.

AML3D look forward to implementing our refocused growth strategy and creating long-term value for shareholders

Indicative Timetable:

Event Date
Announcement of Capital Raising 7 February 2023
Settlement for Placement 13 February 2023
Issue and quotation of Placement Shares 14 February 2023

This announcement has been authorised for release by the Board of AML3D.

For further information, please contact:

Ryan Millar Chief Executive Officer AML3D Limited T: +61 8 8258 2658 E: [email protected]

Hamish McEwin Chief Financial Officer AML3D Limited T: +61 8 8258 2658 E: [email protected]

Page Page | 2

AML3D Limited (ASX:AL3) ACN 602 857 983 | Australian Patent 2019251514

ASX Release 7 February 2023

==> picture [52 x 47] intentionally omitted <==

About AML3D Limited

AML3D Limited, a publicly listed technology company founded in 2014, utilises new technologies to pioneer and lead metal additive manufacturing globally. Disrupting the traditional manufacturing space, AML3D has developed and patented a Wire Additive Manufacturing (WAM[®] ) process that metal 3D prints commercial, largescale parts for Aerospace, Defence, Maritime, Manufacturing, Mining and Oil & Gas. AML3D provides parts contract manufacturing from its Technology Centre in Adelaide, Australia, and is the OEM of ARCEMY®, an industrial metal 3D printing system that combines IIoT and Industry 4.0 to enable manufacturers to become globally competitive.

Page Page | 3

AML3D Limited (ASX:AL3) ACN 602 857 983 | Australian Patent 2019251514